A BuiltForAI Property
Live data · NADAC + Part D CY24 · reviewed daily

Atropine (ATROPEN Auto-Injector)

Anticholinergic class · 0 generic manufacturers · 0 ANDAs filed at FDA.

First FDA approval1971-01-01
Generic availableNo (brand-only)
Shortage statusNone
340B exposureunknown
Last updated
NADAC: weekly (every Wed)Part D Formulary: quarterlyPart D Spend: annual (CY24)Orange Book: weeklyShortages: daily
At a glance · the numbers a plan sponsor wants on screen one
Lowest NADAC
$4.33/unit
16 NDCs benchmarked, lowest of all strengths.
Average NADAC
$9.00
Across all dosage forms in distribution.
Highest NADAC
$20.03
Range is tight.
Plans with PA
1 / 329
Limited PA friction.

Questions a plan sponsor actually asks.

FAQPage schema11 entries indexed · 4 visible
What is Atropine used for?

Atropine is a Anticholinergic medication tracked in Medicare Part D.

Is there a generic for Atropine?

No. Atropine is brand-only with no generic equivalents currently in market.

How much does my plan pay for Atropine?

Across 329 Part D plans, Atropine averages $9.00/unit (NADAC). Lowest available: $4.33/unit. Highest in distribution: $20.03/unit.

Is Atropine on the FDA shortage list?

No. Atropine is not currently on the FDA Drug Shortage Database.

7 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.

Same class. Different math.

Anticholinergic6 alternatives in D1
01
Atropine Injection,
Anticholinergic
Lowest NADAC
0Generic mfrs
CY24 Part D spend
Compare →
02
Atropine Sulfate Injection Usp,
Anticholinergic
Lowest NADAC
0Generic mfrs
CY24 Part D spend
Compare →
03
Benztropine
Anticholinergic
$0.067Lowest NADAC
12Generic mfrs
$35.4MCY24 Part D spend
Compare →
04
Glycopyrrolate
Brand: Cuvposa
$0.103Lowest NADAC
35Generic mfrs
$15.4MCY24 Part D spend
Compare →
05
Ipratropium
Brand: Atrovent
$0.099Lowest NADAC
10Generic mfrs
$244.7MCY24 Part D spend
Compare →
06
Ipratropium and Albuterol
Brand: Combivent Respimat
$0.084Lowest NADAC
4Generic mfrs
CY24 Part D spend
Compare →

Sources · every number above traces back.

Last refresh30 May 2026

Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book · NADAC unit costs: CMS NADAC weekly file (16 NDCs benchmarked) · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.